Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
Myriad Genetics (NASDAQ:MYGN), a molecular diagnostic testing and precision medicine company, announced its participation in two upcoming healthcare investor conferences. Management will present at the Wells Fargo Healthcare Conference on September 4, 2025, at 3:45 PM ET and the Morgan Stanley Annual Global Healthcare Conference on September 10, 2025, at 7:45 AM ET. Both presentations will be available via webcast on the company's investor relations website.
Myriad Genetics (NASDAQ:MYGN), societ脿 attiva nella diagnostica molecolare e nella medicina di precisione, ha annunciato la partecipazione a due prossimi convegni per investitori nel settore sanitario. Il management presenter脿 al Wells Fargo Healthcare Conference il 4 settembre 2025 alle 15:45 ET e al Morgan Stanley Annual Global Healthcare Conference il 10 settembre 2025 alle 07:45 ET. Entrambe le presentazioni saranno disponibili in webcast sul sito web delle relazioni con gli investitori della societ脿.
Myriad Genetics (NASDAQ:MYGN), una compa帽铆a de diagn贸stico molecular y medicina de precisi贸n, anunci贸 su participaci贸n en dos pr贸ximas conferencias para inversores del sector sanitario. La direcci贸n presentar谩 en el Wells Fargo Healthcare Conference el 4 de septiembre de 2025 a las 15:45 ET y en el Morgan Stanley Annual Global Healthcare Conference el 10 de septiembre de 2025 a las 07:45 ET. Ambas presentaciones estar谩n disponibles v铆a webcast en la web de relaciones con inversores de la compa帽铆a.
Myriad Genetics (NASDAQ:MYGN)電� 攵勳瀽 歆勲嫧 氚� 鞝曤皜 鞚橅暀 須岇偓搿�, 雼り皜鞓る姅 霊� 瓯挫潣 項姢旒�鞏� 韴瀽鞛� 旎嵓霟办姢鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 瓴届榿歆勳潃 Wells Fargo Healthcare Conference鞐愳劀 2025雲� 9鞗� 4鞚� 霃欕秬鞁滉皠(ET) 鞓ろ泟 3鞁� 45攵勳棎 氚滍憸頃橂┌, Morgan Stanley Annual Global Healthcare Conference鞐愳劀電� 2025雲� 9鞗� 10鞚� 霃欕秬鞁滉皠(ET) 鞓れ爠 7鞁� 45攵勳棎 氚滍憸頃╇媹雼�. 霊� 氚滍憸 氇憪 須岇偓 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 鞗轨簮鞀ろ姼搿� 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟.
Myriad Genetics (NASDAQ:MYGN), soci茅t茅 sp茅cialis茅e en diagnostics mol茅culaires et m茅decine de pr茅cision, a annonc茅 sa participation 脿 deux prochaines conf茅rences pour investisseurs dans le domaine de la sant茅. La direction pr茅sentera au Wells Fargo Healthcare Conference le 4 septembre 2025 脿 15h45 ET et au Morgan Stanley Annual Global Healthcare Conference le 10 septembre 2025 脿 07h45 ET. Les deux pr茅sentations seront disponibles en webcast sur le site relations investisseurs de la soci茅t茅.
Myriad Genetics (NASDAQ:MYGN), ein Unternehmen f眉r molekulare Diagnostik und Pr盲zisionsmedizin, gab seine Teilnahme an zwei bevorstehenden Healthcare-Investorenkonferenzen bekannt. Das Management wird am Wells Fargo Healthcare Conference am 4. September 2025 um 15:45 Uhr ET und am Morgan Stanley Annual Global Healthcare Conference am 10. September 2025 um 07:45 Uhr ET pr盲sentieren. Beide Pr盲sentationen werden per Webcast auf der Investor-Relations-Website des Unternehmens verf眉gbar sein.
- None.
- None.
SALT LAKE CITY, Aug. 27, 2025 (GLOBE NEWSWIRE) -- . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences.
- The Wells Fargo Healthcare Conference with a fireside chat on Thursday, Sept. 4 at 3:45pm ET.
- The Morgan Stanley Annual Global Healthcare Conference with a fireside chat on Wednesday, Sept. 10 at 7:45am ET.
Links to the live and archived webcasts of both presentations can be viewed at .
About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visit .
Investor Contact听
Matt Scalo听
(801) 584-3532听
听
Media Contact听
Kate Schraml
(224) 875-4493听
FAQ
When is Myriad Genetics (MYGN) presenting at the Wells Fargo Healthcare Conference 2025?
What time is Myriad Genetics presenting at the Morgan Stanley Healthcare Conference 2025?
How can investors access Myriad Genetics' (MYGN) conference presentations?
Which investor conferences is Myriad Genetics (MYGN) attending in September 2025?
